How does suffer from hepatitis small three Yang treat

Update Date: 2023-02-22 Source: Network

summary

If xiaosanyang is suffering from this disease, it is very uncomfortable. In fact, xiaosanyang is only an immune index of hepatitis B virus, which refers to the body immunity of patients with chronic hepatitis B or hepatitis. The appearance of small three Yang also means that the surface antigen in the patient's body and the e antibody and core antibody of hepatitis B are all positive. At present, the big three Yang is usually transformed from the small three yang. Especially after the human body examination, the small three Yang indicates that they have immunity to e antigen. If it is hepatitis B virus DNA positive hepatitis B small three positive patients need to be treated. Let's take a look at the following.

How does suffer from hepatitis small three Yang treat

First, for patients with chronic hepatitis B, the purpose of xiaosanyang treatment is to maximize the long-term stability of hepatitis B virus, reduce the harm of hepatitis B virus to human body, reduce the fibrosis and necrosis of children's liver cells caused by the replication of hepatitis B virus, and delay the liver compensation period caused by xiaosanyang, So as to better improve the quality of life of patients.

Second: Although the emergence of small Sanyang can do antiviral treatment, but not all small Sanyang need to do antiviral treatment, to do antiviral treatment at least to meet the e antigen positive, if e antigen is negative, then at least when the hepatitis B virus DNA content exceeds or equal to 104 copies per milliliter can do antiviral treatment.

Third: if the virus content of patients with small three Yang does not reach the above standard, then there are other situations that need active antiviral treatment, such as the high alanine aminotransferase of patients, and the age of patients has reached 40 years old, this time we need to consider sexual antiviral treatment.

matters needing attention

Xiaosanyang can also be treated by interferon a. At present, the commonly used interferon A in our country is interferon 2a and interferon 1b, and pegylated interferon can also be used in the treatment of small three positive patients with chronic hepatitis B.